Reflections on FDA Draft Guidance on Bayesian Methods in Trials-Protecting Scientific Integrity and Evidentiary Standards

Authors

• Scott R. Evans, Biostatistics Center, George Washington University, Washington, DC.
• Thomas R. Fleming, Department of Biostatistics, University of Washington, Seattle.
• Holly Janes, Fred Hutchinson Cancer Center, Seattle, Washington.
• Lori E. Dodd, Clinical Trials Research and Statistics Branch, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland.

Document Type

Journal Article

Publication Date

3-23-2026

Journal

JAMA

DOI

10.1001/jama.2026.4175

APA Citation

Evans, Scott R.; Fleming, Thomas R.; Janes, Holly; and Dodd, Lori E., "Reflections on FDA Draft Guidance on Bayesian Methods in Trials-Protecting Scientific Integrity and Evidentiary Standards" (2026). GW Authored Works. Paper 8845.
https://hsrc.himmelfarb.gwu.edu/gwhpubs/8845

Department

Biostatistics and Bioinformatics